RUVAX, süstesuspensioon
RUVAX, süstesuspensioon
Not authorised
- Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Product identification
Medicine name:
RUVAX, süstesuspensioon
Active substance:
- Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
-
Pig
-
Sheep
-
Turkey
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Erysipelothrix rhusiopathiae, serotype 2, Inactivated1.00/enzyme-linked immunosorbent assay unit1.00dose
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
-
Meat and offal0day
-
-
Subcutaneous use
- Pig
-
Meat and offal0day
-
- Sheep
-
Meat and offal, milk0day
-
- Turkey
-
Meat and offal0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AB03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Estonia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- RAVIMIAMET
Authorisation number:
- 1200
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Estonian (PDF)
Published on: 3/02/2022
How useful was this page?:
